Texas: According to new research from Ghent, Belgium, intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be a successful technique in combating antimicrobial resistance ...

"Enzyme inhibition promotes bone formation and curbs the development of bone metastases." ScienceDaily. ScienceDaily, 20 December 2022. <www.sciencedaily.com / releases / 2022 / 12 / 221220113003 ...

Researchers can mitigate overactive LRRK2 using MLi-2 LRRK2 kinase inhibitor, a molecule that attaches to the enzyme and decreases its activity. Pfeffer added that because the genetic mutation is not ...